Bicara Therapeutics Inc. Common Stock (BCAX) Analyst Forecast

$10.57

south_east
-$1.26 (-10.65%)
Day's range
$10.52
Day's range
$12.15

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
10/08/2024 Morgan Stanley Judah Frommer $35.00 $24.45   43.15%

Bicara Therapeutics Inc. Common Stock FAQ's

Bicara Therapeutics Inc. Common Stock has been rated by research analysts at Stifel Nicolaus, Morgan Stanley in the past 90 days.